BACKGROUND: The effectiveness of rotavirus vaccines will be dependent on the immunity conferred against prevalent and emergent variants causing severe diarrheal disease. Longitudinal surveillance of disease-causing strains is a prerequisite to intervention. METHODS: Molecular characterization was conducted on rotavirus-positive stool samples from children admitted with diarrhea to a rural district hospital during 2002-2004. Extracted viral RNA was separated by polyacrylamide gel electrophoresis, and rotavirus VP4 (P types) and VP7 (G types) specificities were determined. RESULTS: Among 558 investigated cases, the predominant genotype was P[8]G1 (42%), followed by P[8]G9 (15%), P[4]G8 (7%), P[6]G8 (6%), and P[8]G8 (4%), with 10% mixed strains. Overall, there were 6 different P types and 7 G types. No association was identified between genotype and child age, sex, or severity of diarrhea. The P and G genotypes and polyacrylamide gel electropherotypes showed significant temporal variation in frequency: P[8]G1 decreased from 51% (95% confidence interval [CI], 43%-58%) in 2002 to 30% (95% CI, 24%-37%) in 2004, and P[4]G8 increased from 2% (95% CI, 0%-5%) in 2002 to 13% (95% CI, 9%-19%). Quarterly data revealed seasonally endemic and emergence and/or decay patterns. CONCLUSIONS: Our study of rotavirus strains causing severe diarrhea in rural Kenyan children showed a predominance of P[8]G1 and confirms the importance of G8 and G9 strains in sub-Saharan Africa. Considerable genetic diversity of rotavirus strains was observed, including substantial mixed and unusual types, coupled with significant temporal strain variation and emergence. These results warn of variable vaccine efficacy and the need for long-term surveillance of circulating rotavirus genotypes.
BACKGROUND: The effectiveness of rotavirus vaccines will be dependent on the immunity conferred against prevalent and emergent variants causing severe diarrheal disease. Longitudinal surveillance of disease-causing strains is a prerequisite to intervention. METHODS: Molecular characterization was conducted on rotavirus-positive stool samples from children admitted with diarrhea to a rural district hospital during 2002-2004. Extracted viral RNA was separated by polyacrylamide gel electrophoresis, and rotavirusVP4 (P types) and VP7 (G types) specificities were determined. RESULTS: Among 558 investigated cases, the predominant genotype was P[8]G1 (42%), followed by P[8]G9 (15%), P[4]G8 (7%), P[6]G8 (6%), and P[8]G8 (4%), with 10% mixed strains. Overall, there were 6 different P types and 7 G types. No association was identified between genotype and child age, sex, or severity of diarrhea. The P and G genotypes and polyacrylamide gel electropherotypes showed significant temporal variation in frequency: P[8]G1 decreased from 51% (95% confidence interval [CI], 43%-58%) in 2002 to 30% (95% CI, 24%-37%) in 2004, and P[4]G8 increased from 2% (95% CI, 0%-5%) in 2002 to 13% (95% CI, 9%-19%). Quarterly data revealed seasonally endemic and emergence and/or decay patterns. CONCLUSIONS: Our study of rotavirus strains causing severe diarrhea in rural Kenyanchildren showed a predominance of P[8]G1 and confirms the importance of G8 and G9 strains in sub-Saharan Africa. Considerable genetic diversity of rotavirus strains was observed, including substantial mixed and unusual types, coupled with significant temporal strain variation and emergence. These results warn of variable vaccine efficacy and the need for long-term surveillance of circulating rotavirus genotypes.
Authors: Mirjam Kühne Simmonds; George Armah; Richard Asmah; Indrani Banerjee; Susan Damanka; Mathew Esona; Jon R Gentsch; Jim J Gray; Carl Kirkwood; Nicola Page; Miren Iturriza-Gómara Journal: J Clin Virol Date: 2008-04-02 Impact factor: 3.168
Authors: M Iturriza-Gómara; D Cubitt; D Steele; J Green; D Brown; G Kang; U Desselberger; J Gray Journal: J Med Virol Date: 2000-08 Impact factor: 2.327
Authors: Jelle Matthijnssens; Max Ciarlet; Mustafizur Rahman; Houssam Attoui; Krisztián Bányai; Mary K Estes; Jon R Gentsch; Miren Iturriza-Gómara; Carl D Kirkwood; Vito Martella; Peter P C Mertens; Osamu Nakagomi; John T Patton; Franco M Ruggeri; Linda J Saif; Norma Santos; Andrej Steyer; Koki Taniguchi; Ulrich Desselberger; Marc Van Ranst Journal: Arch Virol Date: 2008-07-05 Impact factor: 2.574
Authors: D James Nokes; John Abwao; Allan Pamba; Ina Peenze; John Dewar; J Kamino Maghenda; Hellen Gatakaa; Evasius Bauni; J Anthony G Scott; Kathryn Maitland; Thomas N Williams Journal: PLoS Med Date: 2008-07-22 Impact factor: 11.069
Authors: Nicholas M Kiulia; Martin M Nyaga; Mapaseka L Seheri; Marianne Wolfaardt; Walda B van Zyl; Mathew D Esona; Grace Irimu; Murithi Inoti; Bernard W Gatinu; Peter K Njenga; Maureen B Taylor; Atunga Nyachieo Journal: Pediatr Infect Dis J Date: 2014-01 Impact factor: 2.129
Authors: Betty E Owor; Mike J Mwanga; Regina Njeru; Robert Mugo; Mwanajuma Ngama; Grieven P Otieno; D J Nokes; C N Agoti Journal: Wellcome Open Res Date: 2019-05-15
Authors: Richard Omore; Sammy Khagayi; Billy Ogwel; Reuben Onkoba; John B Ochieng; Jane Juma; Stephen Munga; Collins Tabu; Sergon Kibet; J Pekka Nuorti; Frank Odhiambo; Jason M Mwenda; Robert F Breiman; Umesh D Parashar; Jacqueline E Tate Journal: BMC Infect Dis Date: 2019-01-11 Impact factor: 3.090
Authors: Albert Jan van Hoek; Mwanajuma Ngama; Amina Ismail; Jane Chuma; Samuel Cheburet; David Mutonga; Tatu Kamau; D James Nokes Journal: PLoS One Date: 2012-10-24 Impact factor: 3.240
Authors: Christabel C Enweronu-Laryea; Kwamena W Sagoe; Susan Damanka; Belinda Lartey; George E Armah Journal: Virol J Date: 2013-09-14 Impact factor: 4.099
Authors: Elisabeth Heylen; Bibi Batoko Likele; Mark Zeller; Stijn Stevens; Sarah De Coster; Nádia Conceição-Neto; Christel Van Geet; Jan Jacobs; Dauly Ngbonda; Marc Van Ranst; Jelle Matthijnssens Journal: PLoS One Date: 2014-06-26 Impact factor: 3.240